Clover Corporation Ltd
ASX:CLV
Intrinsic Value
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. [ Read More ]
The intrinsic value of one
CLV
stock under the Base Case scenario is
0.983
AUD.
Compared to the current market price of 0.525 AUD,
Clover Corporation Ltd
is
Undervalued by 47%.
Clover Corporation Ltd's market capitalization is 87.7m AUD.
CLV stock price is 0.525 AUD.
CLV stock price (0.525 AUD) is 47% less than its Intrinsic Value (0.983 AUD).
CLV stock price (0.525 AUD) is 64% less than its Relative Value (1.449 AUD). Open Relative Valuation
CLV has upside potential of 51% compared to the average analyst price target.
Open Wall St Estimates
CLV has positive Net Income for the last twelve months.
CLV has positive three-year average ROE (Return on Equity): 11%. The company is efficient at transforming stockholders' equity into net income.
CLV has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
CLV's Revenue is forecast to grow at a rate of 4% per year over the next 3 years.
CLV has positive Net Debt. This means that the company has more debt (12m AUD) than cash and short-term investments (8m AUD).
CLV has positive Operating Income for the last twelve months.
CLV's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
CLV's ROE (Return on Equity) for the past 12 months is very low and is equal to 3%.
CLV's Revenue has been falling by 8% per year for the last 3 years.
CLV has positive Free Cash Flow for the last twelve months.
CLV's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 18% to 4%.
CLV has positive Gross Profit for the last twelve months.
CLV's ROE (Return on Equity) has significantly decreased in the last 3 years from 20% to 3%.
CLV's Revenue has dropped by 26% over the past 12 months.
CLV's D/E (Debt to Equity) is very low and is equal to 0.18.
CLV's short-term assets (56m AUD) exceed its short-term liabilties (7m AUD).
CLV's long-term assets (85m AUD) exceed its long-term liabilties (20m AUD).
CLV's Altman Z-Score is very high and is equal to 6.13.
Valuation Backtest
Clover Corporation Ltd
Run backtest to discover the historical profit from buying and selling
CLV
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Clover Corporation Ltd
Balance Sheet Decomposition
Clover Corporation Ltd
| Current Assets | 56.2m |
| Cash & Short-Term Investments | 8.1m |
| Receivables | 13.1m |
| Other Current Assets | 35m |
| Non-Current Assets | 28.7m |
| Long-Term Investments | 11.7m |
| PP&E | 12.4m |
| Intangibles | 1.9m |
| Other Non-Current Assets | 2.7m |
| Current Liabilities | 6.5m |
| Accounts Payable | 1.7m |
| Accrued Liabilities | 861k |
| Other Current Liabilities | 3.9m |
| Non-Current Liabilities | 13.1m |
| Long-Term Debt | 11.9m |
| Other Non-Current Liabilities | 1.2m |
Earnings Waterfall
Clover Corporation Ltd
|
Revenue
|
62.8m
AUD
|
|
Cost of Revenue
|
-45.6m
AUD
|
|
Gross Profit
|
17.2m
AUD
|
|
Operating Expenses
|
-13.2m
AUD
|
|
Operating Income
|
4.1m
AUD
|
|
Other Expenses
|
-2.1m
AUD
|
|
Net Income
|
1.9m
AUD
|
Free Cash Flow Analysis
Clover Corporation Ltd
What is Free Cash Flow?
CLV Profitability Score
Profitability Due Diligence
Clover Corporation Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
Clover Corporation Ltd's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
CLV Solvency Score
Solvency Due Diligence
Clover Corporation Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Clover Corporation Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CLV Price Targets Summary
Clover Corporation Ltd
According to Wall Street analysts, the average 1-year price target for
CLV
is 0.791 AUD
with a low forecast of 0.606 AUD and a high forecast of 0.998 AUD.
Shareholder Return
CLV Price
Clover Corporation Ltd
| Average Annual Return | -7.53% |
| Standard Deviation of Annual Returns | 30.43% |
| Max Drawdown | -84% |
| Market Capitalization | 87.7m AUD |
| Shares Outstanding | 166 999 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Clover Corporation Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.
Contact
IPO
Employees
Officers
The intrinsic value of one
CLV
stock under the Base Case scenario is
0.983
AUD.
Compared to the current market price of 0.525 AUD,
Clover Corporation Ltd
is
Undervalued by 47%.
You don't have any saved screeners yet
